
Leading Clinical Trial Supplies End Use Markets Databank
Description
Leading Clinical Trial Supplies End Use Markets Databank
The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device segment is anticipated to reach $959.0 Million by 2029 with the highest CAGR of 7.58%. Pharmaceutical and Medical device segments collectively expected to account for about 70.4% share of the Clinical Trial Supplies market in 2020, with the former constituting around 46.5% share. Medical device and Biologics segments are expected to witness significant growth rates at a CAGR of 7.58% and 7.53% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.4% in the overall Clinical Trial Supplies market in 2020, and is anticipated to reach 38.6% by 2029.
The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device segment is anticipated to reach $959.0 Million by 2029 with the highest CAGR of 7.58%. Pharmaceutical and Medical device segments collectively expected to account for about 70.4% share of the Clinical Trial Supplies market in 2020, with the former constituting around 46.5% share. Medical device and Biologics segments are expected to witness significant growth rates at a CAGR of 7.58% and 7.53% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.4% in the overall Clinical Trial Supplies market in 2020, and is anticipated to reach 38.6% by 2029.
Table of Contents
85 Pages
- 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY END USE
- 1.1. OVERVIEW
- 1.2. PHARMACEUTICAL
- 1.2.1 PHARMACEUTICAL MARKET, BY REGION
- 1.2.1.1 North America Pharmaceutical Market, By Country
- 1.2.1.2 Europe Pharmaceutical Market, By Country
- 1.2.1.3 Asia-Pacific Pharmaceutical Market, By Country
- 1.2.1.4 Rest of World Pharmaceutical Market, By Country
- 1.3. BIOLOGICS
- 1.3.1 BIOLOGICS MARKET, BY REGION
- 1.3.1.1 North America Biologics Market, By Country
- 1.3.1.2 Europe Biologics Market, By Country
- 1.3.1.3 Asia-Pacific Biologics Market, By Country
- 1.3.1.4 Rest of World Biologics Market, By Country
- 1.4. MEDICAL DEVICE
- 1.4.1 MEDICAL DEVICE MARKET, BY REGION
- 1.4.1.1 North America Medical device Market, By Country
- 1.4.1.2 Europe Medical device Market, By Country
- 1.4.1.3 Asia-Pacific Medical device Market, By Country
- 1.4.1.4 Rest of World Medical device Market, By Country
- 1.5. OTHER END USES
- 1.5.1 OTHER END USES MARKET, BY REGION
- 1.5.1.1 North America Other End uses Market, By Country
- 1.5.1.2 Europe Other End uses Market, By Country
- 1.5.1.3 Asia-Pacific Other End uses Market, By Country
- 1.5.1.4 Rest of World Other End uses Market, By Country
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.